GnRH agonistReproductive Peptides
Histrelin (Vantas/Supprelin)
A synthetic nonapeptide GnRH agonist available as a subcutaneous implant. FDA-approved for central precocious puberty (Supprelin LA) and advanced prostate cancer (Vantas). Provides continuous GnRH receptor stimulation leading to desensitization.
GnRH-agonistprostate-cancerprecocious-pubertyimplantFDA-approved
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A synthetic nonapeptide GnRH agonist available as a subcutaneous implant. FDA-approved for central precocious puberty (Supprelin LA) and advanced prostate cancer (Vantas). Provides continuous GnRH rec…